Portal de investigación
Role of the receptor for advanced glycation end products (RAGE) in blood as a potential biomarker for progression to olaparib: A post hoc analysis of patients with platinum-resistant ovarian cancer (PROC) treated in the ROLANDO-GEICO 1601 trial
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Perez-Fidalgo, JA
- Tavira, B
- Pena, Carlos J.
- Guerra, E
- Martínez-Pretel, JJ
- García, Y
- Pineda, B
- Iglesias, M
- Hernández-Sosa, M
- Estévez-García, P
- Sánchez, LM
- González-Martín, A
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Perez,JA,Tavira,B,Pena,CJ,Guerra,E,Martínez,JJ,García,Y,Pineda,B et al. Role of the receptor for advanced glycation end products (RAGE) in blood as a potential biomarker for progression to olaparib: A post hoc analysis of patients with platinum-resistant ovarian cancer (PROC) treated in the ROLANDO-GEICO 1601 trial. Special Clinical Science Symposia. 2024. TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103:LIPPINCOTT WILLIAMS & WILKINS. 2024.